Skip to main content

MoneyWorks4Me

Lupin informs about press release

10 Jan 2024 Evaluate
Lupin has informed that it enclosed a Press release regarding launch of Varenicline Tablets, 0.5 mg and 1 mg, after having received approval from the US FDA. This may be considered as a disclosure pursuant to Regulation 30 of the Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1882.35
Dr. Reddys Labs. 1396.00
Cipla 1428.00
Lupin 1962.90
Zydus Lifesciences 1200.50
View more..